Small changes in six-minute walk distance are important in diffuse parenchymal lung disease

被引:102
作者
Holland, Anne E. [1 ,2 ]
Hill, Catherine J. [3 ,4 ]
Conron, Matthew [5 ]
Munro, Prue [1 ]
McDonald, Christine F. [4 ,6 ]
机构
[1] Alfred Hosp, Dept Physiotherapy, Melbourne, Vic 3004, Australia
[2] La Trobe Univ, Sch Physiotherapy, Bundoora, Vic 3086, Australia
[3] Austin Hlth, Dept Physiotherapy, Heidelberg, Vic 3084, Australia
[4] Inst Breathing & Sleep, Heidelberg, Vic 3084, Australia
[5] St Vincents Hosp, Dept Resp Med, Victoria Parade Fitzroy, Vic 3065, Australia
[6] Austin Hlth, Dept Resp & Sleep Med, Heidelberg, Vic 3084, Australia
关键词
Exercise test; Outcome assessment; Pulmonary fibrosis; IDIOPATHIC PULMONARY-FIBROSIS; QUALITY-OF-LIFE; CLINICALLY IMPORTANT DIFFERENCE; INTRAINDIVIDUAL CHANGES; INTERSTITIAL PNEUMONIA; ARTERIAL-HYPERTENSION; PROGNOSTIC VALUE; HEALTH-STATUS; SURVIVAL; MEANINGFUL;
D O I
10.1016/j.rmed.2009.04.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to determine the minimal important difference for the six-minute walk distance in people with diffuse parenchymal tung disease. Methods: Forty-eight subjects (24 idiopathic pulmonary fibrosis) undertook the six-minute walk test before and after an 8-week exercise program. The minimal important difference was calculated using a distribution-based and an anchor-based method. A global rating of change scale was used as the external criterion to judge patients as clinically unchanged or changed. Results: The mean change in six-minute walk distance in improved subjects was 50.0 m, compared to 4.0 m in unchanged subjects and a reduction of 64.3 m in those classified as worse (p < 0.001). The receiver operating characteristic curve indicated a cut-off value for meaningful change of 30.5 m (area under the curve 0.89, 95% confidence interval 0.81-0.98) whilst the standard error of the mean method indicated a value of 33 m. Similar values were obtained when only subjects with idiopathic pulmonary fibrosis were included (29 and 34 m, respectively). Conclusions: Small differences in six-minute walk distance, in the range 29-34 m, may be clinically significant for people with diffuse parenchymal lung disease. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1430 / 1435
页数:6
相关论文
共 36 条
[1]  
American Thoracic Society, 2000, AM J RESP CRIT CARE, V161, P646
[2]  
[Anonymous], 1994, An introduction to the bootstrap: CRC press
[3]  
[Anonymous], AM J RESP CRIT CARE
[4]   Six-minute walk test and health status assessment in sarcoidosis [J].
Baughman, Robert P. ;
Sparkman, Brian K. ;
Lower, Elyse E. .
CHEST, 2007, 132 (01) :207-213
[5]   Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research [J].
Beaton, DE ;
Boers, M ;
Wells, GA .
CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (02) :109-114
[6]   How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure [J].
Brozek, Jan L. ;
Guyatt, Gordon H. ;
Schuenemann, Holger J. .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2006, 4 (1)
[7]  
Chetta A, 2001, SARCOIDOSIS VASC DIF, V18, P170
[8]   Sildenafil improves walk distance in idiopathic pulmonary fibrosis [J].
Collard, Harold R. ;
Anstrom, Kevin J. ;
Schwarz, Marvin I. ;
Zisman, David A. .
CHEST, 2007, 131 (03) :897-899
[9]   Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis [J].
Collard, HR ;
King, TE ;
Bartelson, BB ;
Vourlekis, JS ;
Schwarz, MI ;
Brown, KK .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (05) :538-542
[10]  
DEYO RA, 1991, CONTROLLED CLIN TRIA, V12, P1425